01 March 2006
Immune responses to isolated human skin antigens in actinic prurigo.
Alberto Gómez, Angela Umana, Alba Alicia TrespalaciosMed Sci Monit 2006; 12(3): BR103-113 :: ID: 447104
Abstract
Background: Actinic prurigo (AP) is a frequent photodermatosis among Amerindians,with a high incidence among women and children below ten years of age. Neither the cause of actinic prurigonor its etiological agent have been described. Not much is known about the pathogenic mechanisms of thedisease, although associations with the human leucocitary antigens (HLA) and local immune responses seemto play an important role in its expression, as is the case in other skin autoimmune disorders, suchas pemphigus and psoriasis. Material/Methods: In this paper we compare cellular and humoral immunitythrough in vitro proliferation studies, ELISA and immunofluorescence tests in actinic prurigo patientsand healthy controls. Results: Autoantibody reactivities on the skin and also proliferative responsesto isolated autologous skin antigens were higher in patients than in controls. The polyclonal cellularimmune response against T cell mitogens and against allogeneic stimuli was found to be diminished inpatients. Conclusions: We found autoimmune reactivity in patients suffering from actinic prurigo. Wepostulate that AP patients may have one or more skin antigens that stimulate an autoimmune response,which causes the observed skin lesions. As AP is a pathology that affects mainly the skin, any immuneresponse should be localized and the observed infiltrating lymphocytes in skin biopsies should be activatedby these hypothetical antigens.
Keywords: Fluorescent Antibody Technique, Indirect, T-Lymphocytes - immunology, Skin - immunology, Prurigo - immunology, Photosensitivity Disorders - immunology, Immunity, Innate, Immunity, Cellular, Fluorescent Antibody Technique, Direct, Enzyme-Linked Immunosorbent Assay, Child, Case-Control Studies, Biopsy, Autoimmunity, Antigens - immunology, Adolescent
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952